Table 4 Newborn clinical conditions and neurodevelopmental disorders
Treated hemolytic NHB cohort | Matched non-NHB cohort | p-value1 | |
|---|---|---|---|
Clinical conditions during 30 days after birth, total n | 1,373 | 1,373 | |
Breech delivery and extraction affecting fetus or newborn, n (%) | 114 (8.3) | 107 (7.8) | 0.579 |
Birth trauma and hemorrhage, n (%) | 62 (4.5) | 33 (2.4) | 0.003 |
Delivery by vacuum extractor affecting fetus or newborn, n (%) | 26 (1.9) | 11 (0.8) | 0.014 |
Polycythemia neonatorum, n (%) | 11 (0.8) | 0 (0) | 0.001 |
Other malpresentation, malposition, and disproportion during labor and delivery affecting fetus or newborn, n (%) | 9 (0.7) | 9 (0.7) | 1.000 |
Forceps delivery affecting fetus or newborn, n (%) | 5 (0.4) | 7 (0.5) | 0.564 |
Neonatal hematemesis and melena due to swallowed maternal blood, n (%) | 0 (0) | 0 (0) | _ |
Neurodevelopmental disorders during one year after birth, total n | 765 | 765 | |
Kernicterus, n (%) | 9 (1.2) | 0 (0) | 0.004 |
Motor dysfunction, n (%) | 4 (0.5) | 2 (0.3) | 0.687 |
Hearing loss, n (%) | 3 (0.4) | 2 (0.3) | 1.000 |
Encephalopathy, n (%) | 2 (0.3) | 2 (0.3) | 1.000 |
Abnormal behavior, n (%) | 1 (0.1) | 3 (0.4) | 0.625 |
Cerebral palsy, n (%) | 1 (0.1) | 0 (0) | 1.000 |
Vision loss, n (%) | 0 (0) | 2 (0.3) | 0.500 |
Neurodevelopmental delay, n (%) | 0 (0) | 1 (0.1) | 1.000 |
Cognitive disorders, n (%) | 0 (0) | 0 (0) | _ |
Language disorders, n (%) | 0 (0) | 0 (0) | _ |